Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8492391
APP PUB NO 20120070512A1
SERIAL NO

13375343

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to substituted 6-(2-hydroxybenzylamino)purines of general formula I, to their activity as cyclin-dependent kinases 2, 5, 7 and 9 inhibitors and to their use as medicaments, particularly in the treatment of disorders involving cell proliferation or inflammation. The invention further includes pharmaceutical compositions containing the substituted 6-(2-hydroxybenzylamino)purines.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERZITA PALACKEHO V OLOMOUCI779 00 OLOMOUC
BIOPATTERNS S R OSLECHTITELU 813/21 OLOMOUC HOLICE 779 00

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dolezal, Karel Hlubocky, CS 27 344
Havlicek, Libor Praha, CS 10 118
Jorda, Radek Olomouc, CS 5 1
Krystof, Vladimir Olomouc, CS 14 359
Popa, Igor Olomouc, CS 6 169
Strnad, Miroslav Olomouc, CS 49 729
Zatloukal, Marek Sumperk, CS 24 305

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 23, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00